|
KIFAP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.73640000003628E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0456000004998E-07 |
| Normal-vs-Stage2 |
1.778340E-04 |
| Normal-vs-Stage3 |
4.938000E-02 |
| Normal-vs-Stage4 |
1.230430E-01 |
| Stage1-vs-Stage2 |
4.674800E-01 |
| Stage1-vs-Stage3 |
7.076300E-02 |
| Stage1-vs-Stage4 |
1.188390E-01 |
| Stage2-vs-Stage3 |
6.479800E-02 |
| Stage2-vs-Stage4 |
8.682000E-02 |
| Stage3-vs-Stage4 |
9.325600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.52550000000118E-05 |
| Normal-vs-AfricanAmerican |
8.990000E-01 |
| Normal-vs-Asian |
1.201710E-02 |
| Caucasian-vs-AfricanAmerican |
5.909900E-02 |
| Caucasian-vs-Asian |
7.488600E-01 |
| AfricanAmerican-vs-Asian |
1.220550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87150000003E-06 |
| Normal-vs-Female |
3.89860000000741E-05 |
| Male-vs-Female |
2.877800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04059999994632E-06 |
| Normal-vs-Age(41-60Yrs) |
1.570450E-04 |
| Normal-vs-Age(61-80Yrs) |
6.163700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.245800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.334200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.565200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.216300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.572600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.949210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.898400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.330000E-01 |
| Classical-VS-Follicular |
7.49609999628476E-08 |
| Classical-VS-Other |
1.616160E-01 |
| Classical-VS-Normal |
3.943700E-03 |
| Tall-VS-Follicular |
2.187700E-04 |
| Tall-VS-Other |
9.281600E-02 |
| Tall-VS-Normal |
2.193000E-01 |
| Follicular-VS-Other |
8.568600E-01 |
| Follicular-VS-Normal |
3.25619531338361E-11 |
| Other-VS-Normal |
2.298400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47820000076615E-08 |
| Normal-vs-N1 |
1.702320E-03 |
| N0-vs-N1 |
6.413000E-01 |
|
|
